At the IGTP TODAY

News

- Campus Can Ruti, Research

Rice against HIV: a three-protein cocktail produced in seeds shows potent HIV neutralization in vitro

Researchers from University of Lleida-Agrotecnio, IrsiCaixa AIDS Research Institute and ICREA obtained for the first time three different anti-HIV proteins from a single transgenic rice plant and crude extracts from it averted HIV from entering in human cells in vitro. Rice components showed an enhancing effect, further helping to block HIV infectivity. Dr Julià Blanco, researcher from the Institut Germans Trias i Pujol at IrsiCaixa, where he leads the Cell Virology and Immunology group, participated in the study.

The Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) opens for business

In June this year the new Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) started its normal working activities.  Located at the highest point of the campus, the CMCiB is a centre promoted by the Germans Trias i Pujol Research Institute (IGTP) and dedicated to biomedical research and training.  The centre is an important addition to scientific infrastructures in southern Europe and is the only one in Spain, it has been set up to become a reference in comparative medicine, bioimaging and computational models with a clear remit to promote alternative research models and methods

- Research

An IGTP paper in the top 100 most read papers of Scientific Reports

A paper published by the IGTP Kidney-affecting Research Group (REMAR) is in the top 100 most read cellular biology papers in Scientific Reports in 2017.  The journal published around one thousand articles on cellular biology last year, making the ranking especially remarkable for this paper on which Dr Francesc Borràs is co-corresponding author.  The paper is ranked at 54.

- Innovation

Aniling chosen for an intensive preparation program for Boston

The IGTP-PMPPC applied health technology spin-off is one of five selected by ACCIÓ in the first edition of 'Road to Boston'. Aniling is one of five applied health technology Catalan start-ups that has started an intensive six-month tailored program to prepare for entry to Boston, one of the principal hubs in this field, to establish first contacts with key players in the sector.  

- Projects, Research

The IGTP closes its successful coordination of a COST Project to develop cellular therapies

Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis.  To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.

- Research

The Hereditary Cancer Group at the IGTP provides another tool for the better management of patients diagnosed with NF1

In a study, published in Human Mutation led by Meritxell Carrió and Eduard Serra of the IGTP in collaboration with scientists from the ICO Hereditary Cancer Program, scientists studied 8 PNF tumours to find information to help doctors predict how tumours will develop.  They looked at the tissue characteristics of the tumors and then compared this to the genetic make-up of the cells within the tumour.